Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Asahi Group Foods is a prominent Japanese company operating as a core subsidiary of Asahi Group Holdings, focusing on the food and healthcare sectors. Formed through the strategic integration of Asahi Food & Healthcare, Wakodo, and Amano Jitsugyo, the company leverages deep expertise in infant nutrition, freeze-drying technology, and health supplements. Its diverse product portfolio includes the market-leading Wakodo baby food brand, the Dear-Natura supplement line, and MINTIA breath mints. The company is heavily involved in the research and development of functional ingredients, particularly lactic acid bacteria and yeast-derived components, to address wellness needs across all life stages. Asahi Group Foods maintains a strong presence in the Japanese consumer market while expanding its reach in the broader Asian region. The company's commitment to quality and innovation is reflected in its extensive manufacturing capabilities and its role as a leader in the Japanese baby food market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Asahi Group Foods.